Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

2013415 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Diabetes & Endocrinology

Volume 1, Issue 4, pp. 295-305

Field-Weighted Citation Impact: 19.27